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Final extents of fusion of influenza virus (A/PR/8/34
strain) with neutral and partially acidic liposomes were
monitored with (i) a fluorescence resonance energy-
transfer assay in which the liposomes were labeled and
(ii) by the dequenching of octadecylrhodamine, initially
incorporated in the viral membrane. The latter assay
was also employed in the fusion of influenza virus and
Sendai virus with erythrocyte ghosts. In all cases, a
phenomenon of partial fusion activity of the virus was
observed, which is distinct from low pH inactivation.
The unfused influenza or Sendai virions, which were
separated by sucrose gradient centrifugation from lipo-
somes or erythrocyte ghosts exhibited again partial fu-
sion activity toward freshly added liposomes or ghosts,
respectively. The conclusion is that the fraction of ini-
tially bound and unfused virions does not consist of
defective particles, but rather of particles bound to the
target membranes via inactive sites on the virus (or on
cellular membranes), or else, partial fusion activity is a
manifestation of a certain probability of production of
fusion inactive sites by irreversible association of viral
glycoproteins or peptides in the target membrane.
Analysis of final extents of virus-liposome fusion demon-
strates that all three viruses studied, influenza virus (1–4),
Sendai virus (5–7), and HIV-11 (8), exhibit partial fusion activ-
ity toward liposomes of certain compositions, e.g. in certain
cases only 20–40% of the virions fuse. For influenza virus and
Sendai virus fusing with cells, the results in several cases
indicate complete fusion activity, i.e. close to 100% of the virus
particles can fuse with erythrocyte ghosts and with several
suspension cells, provided that the number of virions per cell
does not exceed a certain limit of the order of tens to hundreds,
depending on the size and composition of the cellular mem-
branes (3, 9–14). However, other studies (15) do indicate in-
complete fusion activity of these viruses with cellular mem-
branes. Furthermore, in the case of several immunodeficiency
viruses, such as HIV-1, only a small fraction of the virions fuse
with the cellular target membranes (8, 16).
In the current study, we first present details of the mecha-
nisms of partial fusion activity of influenza virus toward lipo-
somes. At pH 5 and 37 °C, influenza virus exhibits 100% fusion
activity toward the acidic liposomes PS and cardiolipin,
whereas only 20–40% of the virions are capable of fusing with
liposomes composed of PC/PE with or without cholesterol and
gangliosides (2, 4). The phenomenon of partial fusion activity
should not be confused with low pH inactivation of fusion
activity that has been observed in the case of influenza virus (3,
4, 13–15, 17–21). Thus, the reduction in the fusion rate con-
stant upon exposure of influenza virus to low pH is similar
when the target membrane of a liposome is composed of PS or
PC/PE/cholesterol with or without gangliosides, but the final
extents of fusion are 100% and 20–40%, respectively (4). Fur-
thermore, at neutral pH, Sendai virus and HIV-1 are not inac-
tivated but they exhibit partial fusion activity toward lipo-
somes. Following a previously described procedure (22), results
with Sendai virus fusing with liposomes2 (3), indicated that
bound, unfused virions can be released by sucrose gradient
centrifugation. The separated unfused virions subsequently
fused when incubated with a “fresh” batch of liposomes. Hence,
the fraction of initially bound unfused Sendai virions does not
consist of defective particles, but rather of particles bound to
liposomes via “inactive” sites.
In the current study, we also looked at the effect of temper-
ature on the final extents of fusion of Sendai virus and influ-
enza virus with liposomes and erythrocyte ghosts. Interest-
ingly, in most cases, the fraction of fusing virions increased
with temperature, despite the accelerated inactivation of influ-
enza virus at higher temperatures.
EXPERIMENTAL PROCEDURES
Materials
PC, PS, and PE were purchased from Avanti Polar Lipids Inc. (Bir-
mingham, AL). Cholesterol and gangliosides were from Sigma, C12E8
was from Calbiochem, R18, NBD-PE and Rh-PE were from Molecular
Probes Inc. (Eugene, OR).
Methods
Virus Preparations—Influenza virus, A/PR/8/34 (H1N1) strain, was
obtained from SPAFAS Inc. (Preston, CT). The virus was grown for 48 h
at 37 °C in the allantoic cavity of 11-day-old embryonated eggs, purified
by discontinuous sucrose density gradient centrifugation and stored at
270 °C in phosphate-buffered saline. Sendai virus (hemagglutinating
virus of Japan) Z strain was obtained from SPAFAS Inc. (Preston, CT).
The virus was grown for 72 h in the allantoic cavity of 10-day-old
embryonated eggs, purified by differential centrifugation, and stored at
270 °C in phosphate-buffered saline.
Liposome Preparation—Large unilamellar lipid vesicles (LUVs) were
prepared by the reverse phase evaporation method in 150 mM NaCl, 10
mM Hepes, pH 7.4, as described (23). The vesicles were sized through
0.1-mm polycarbonate filters, and their concentration was determined
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by a phosphate assay. For the RET assay (24), LUVs were prepared
with 0.6 mol% of both NBD-PE and Rh-PE incorporated in the lipid
membrane.
Virus Labeling—Viral preparations were labeled with octadecylrho-
damine B chloride as described previously (25, 26). The final self-
quenching concentration of added probe corresponded to approximately
5 mol% of total viral lipid and that of ethanol was less than 1% (v/v). The
mixture was incubated in the dark for 30 min at room temperature.
R18-labeled virus was separated from noninserted fluorophore by chro-
matography on Sephadex G-75 (Pharmacia, Uppsala, Sweden) using
150 mM NaCl, 10 mM Hepes, pH 7.4, as elution buffer. The protein
concentration of the labeled virus was determined by the Lowry assay.
Experiments with Liposomes—With the R18 assay fusion between
labeled influenza virus particles (10 mg/ml viral protein) and unlabeled
LUVs (25 mM) was monitored continuously by the relief of R18 fluores-
cence self-quenching (25, 26). Excitation was set at 560 nm and emis-
sion at 590 nm. With the RET assay, fusion between unlabeled influ-
enza virus (20 mg/ml) and NBD/Rh-labeled (0.6 mol% each) lipid
vesicles (5 mM) was followed by an increase of NBD fluorescence with
465 nm and 530 nm set in the excitation and emission monochromators,
respectively (24).
The final incubation volume was always 1.5 ml in 135 mM NaCl, 5
mM sodium acetate, 5 mM Mes, 5 mM Hepes buffer. Following an initial
15-min incubation at pH 7.4, the virus-liposome suspension was acidi-
fied to pH 5.0, and fusion was monitored for the times and at the
temperatures indicated below. The fluorescence scales were calibrated,
such that the initial fluorescence of virus-liposome mixtures was set at
0% fluorescence. The value obtained by detergent lysis after each ex-
periment was set at 100% fluorescence. With the R18 assay, Triton
X-100, at a final concentration of 1% (v/v), was used. In the case of the
RET assay, final fluorescence levels were obtained with C12E8 (1 mM).
All fluorescence measurements were performed in a Perkin-Elmer
LS-50 luminescence spectrometer or in a SPEX Fluorolog spectrofluo-
rimeter. The sample chamber was equipped with a magnetic stirring
device, and the temperature was controlled with a thermostatted cir-
culating water bath.
Separation of Unfused Virus Particles and Second Round Fusion
Experiments—In “second round” fusion experiments, both assays were
carried out as described above. However, following the appropriate
times for fusion at different temperatures and at pH 5.0, the mixtures
were then neutralized and overlaid on discontinuous sucrose density
gradients. Gradients were then centrifuged at 250,000 3 g in a Beck-
man ultracentrifuge to recover unfused virus particles from the gradi-
ent and thus separate them from LUVs and fusion products. Recovered
virus particles were diluted in experimental buffer and their fusion
activity toward LUVs of fresh batches was assayed using the same
procedure (i.e. same liposome concentrations) as in the “first round,”
only in this case with a final addition of detergent. Control experiments
showed that the use of virus concentrations below 10 mg/ml viral protein
did not affect the final extent of fluorescence increases in the applica-
tion of the R18 assay.
Experiments with Erythrocyte Ghosts—Human erythrocyte ghosts
were prepared as described (27). Fusion activity of Sendai virus and
influenza virus toward erythrocyte ghosts was monitored as a function
of R18 dequenching, as in the case of the experiments using LUVs as
target membranes. The experimental temperatures and respective
times of incubation are mentioned under “Results.” In all experiments,
the concentration of viral protein in the first round was 2.5 mg/ml and
that of erythrocyte ghost protein was 10 mg/ml. While Sendai virus
fuses immediately at neutral pH, influenza virus was always allowed to
bind to the target membranes for 15 min at pH 7.4, after which the
medium was acidified to pH 5.
In first round experiments, an initial fluorescence reading (F0) was
taken before the onset of fusion. Following the incubation times re-
quired to obtain final extent levels of fluorescence, the mixture was
neutralized (in the case of influenza virus) and ghosts were pelleted by
centrifugation (12,000 3 g, 0 °C), thus removing unbound virions. Flu-
orescence in the resuspended pellet (bound and/or fused virus particles)
was measured before (Ft) and after the addition of detergent (F`). The
percentage of fusion in this case only takes into account bound virions
and was calculated according to the formula: % fusion 5 100z(Ft 2
F02)/(F` 2 F02) with F02 5 F0zF`/F`,0 where F`,0 corresponds to the
fluorescence intensity obtained when detergent was added directly to
the initial virus preparation (with fluorescence F0).
In second round experiments, an initial fluorescence reading (F0) was
also taken before the onset of fusion. Following final extent incubations,
the mixture was neutralized (in the case of influenza virus), and ghosts
were again pelleted by centrifugation. The pellet was then resuspended
and layered on a sucrose density gradient, and unfused virus particles
were recovered by ultracentrifugation as described for LUV experi-
ments. These recovered virions were diluted in buffer, and their
(quenched) fluorescence was measured (f0). The fraction (b) of ghost
protein added as a target membrane in this second round was calcu-
lated by the formula b 5 f0/F0 so as to maintain the same virus/ghost
ratio in the second round. After mixing recovered virus with fresh
ghosts, R18 dequenching was again monitored for the same time as in
the first round (at neutral pH for Sendai virus; at low pH following a
binding period of 15 min at pH 7.4 for influenza virus). When the
incubation was concluded, ghosts were again pelleted by centrifugation
and fluorescence in the resuspended pellet was measured before (ft) and
TABLE I
Final intensity (I) levels and percents of virions fusing for influenza virus labeled by R18 interacting with excess of liposomes
The concentration of viral protein was 10 mg/ml, which amounts to a lipid concentration of 2.8 mM. Liposome concentration was 25 mM lipid. The
virus was labeled by the R18 probe as described under “Experimental Procedures.” The calculations of % fusion activity were described in Ref. 6.
Each point represents an average of 3 to 5 cases.
Liposome
composition Temperature
First round Time of incubation
at pH 5
Second round
I (%) % fusion activity I (%) % fusion activity
(°C) h
PC/PE 37 23.5 6 4 26 6 4 6 12.3 6 2 14 6 2
(2:1) 20 13.5 6 1.5 15 6 1.5 8 7.4 6 1.5 8.5 6 1.5
PC/PE/cholesterol
(2:1:1)
37 24.7 6 4 27 6 4 8 15.2 6 2 17 6 2
TABLE II
Final intensity (I) levels and percents of virions fusing for influenza virus interacting with labeled liposomes
The concentration of viral protein was 20 mg/ml, which amounts to a lipid concentration of 5.6 mM. Liposome concentration was 5 mM lipid. The
liposomes were labeled with NBD-PE and Rh-PE at a surface concentration of 0.6 mol% each. The calculations of % fusion activity were as
described in Refs. 3 and 6. Each point represents an average of 3 to 5 cases. In second fusion rounds, the liposome concentration was the same,
but the concentration of recovered virus was 28% (25–30%) of that in the first round. This accounts for the larger ratio between calculated % fusion
activity and I (%) in the second fusion round.
Liposome composition Temperature
First round Time of incubation
at pH 5
Second round




37 20.3 6 3 55 6 5 15 min 8.8 6 2 40 6 10
20 24.8 6 3 65 6 5 1 h 5.4 6 3 24 6 12
4 24.2 6 3 63 6 5 7 h 5.8 6 2.5 25 6 10
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after (f`) the addition of detergent. The percentage of fusion in the
second round was then calculated using the formulas mentioned above
for first round experiments.
RESULTS
The first aim of the experiments was to test whether virions
that do not fuse with the liposomes are capable of fusing with
freshly added liposomes after their separation by prolonged
centrifugation in sucrose gradients. The experiments also
tested the effect of temperature on partial fusion activity of
influenza virus. In order to avoid a possible criticism that
exchange of the R18 probe can occur, we have employed two
fusion assays. In the application of the R18 assay (25, 26), the
labeled virus interacted with unlabeled liposomes in large ex-
cess. In this assay, probe dilution into liposomal membranes
results in an increase in fluorescence intensity. Hence, if all the
virions are capable of fusing, the increase in fluorescence in-
tensity can approach 100% (6). In the application of the RET
fusion assay (24) where N-NBD-PE and N-Rh-PE were incor-
porated in the bilayer of the liposomes, fusion of liposomes with
the virus was monitored by an increase in the fluorescence
intensity of NBD due to its dilution within the fusion products.
According to the analysis (1), the extent of fluorescence inten-
sity increase in the application of the RET assay is limited to
50% in the presence of a large excess of virions, whereas for a
suspension consisting of equal numbers of fusion-active virions
and liposomes, the extent of fluorescence increase is below 40%.
Consequently, we employed the R18 fusion assay in fusion
experiments with PC/PE (2:1) and PC/PE/cholesterol (2:1:1)
liposomes (Table I), in which cases the percents of influenza
virions capable of fusing could be estimated in the range of
20–40% according to the results of Ref. 4, whereas the RET
assay was used in fusion studies with PC/PE/PS/cholesterol
(1:1:1:1) where the percent of fusion-active virions was larger
(Table II). We have also carried out a few experiments in which
both assays were employed with the same liposome composi-
tions (Table III). The tables also provide the estimated percents
of virions capable of fusing in the first round. The calculations
assumed that the binding of fusion-inactive virions was essen-
tially irreversible (6).
Tables I and II show that at 37 °C influenza virus exhibits
partial fusion activity toward the liposomes of the compositions
used, the percents of virions capable of fusing varying from 26
to 55. In all three cases, the released virions were capable of
fusing with freshly added liposomes. The fractions of virions
capable of fusing in the second round varied from 14 to 40%. No
further increase in fluorescence intensity at 37 °C was ob-
served by prolonging significantly the incubation times beyond
the indicated values. The explanation that is favored is that the
virions that did not fuse in the first round happened to bind to
the liposomes via sites on the viral membrane, in such a fash-
ion that the virus could not fuse and that this binding was
essentially irreversible.
A comparison of the results obtained by the application of
both assays (Table III) illustrates that despite the significantly
smaller extents of fluorescence increase with the RET assay,
the estimated percents of virions capable of fusing in the first
fusion round were similar, albeit somewhat larger with the R18
assay. This difference is indicative of a small degree of probe
exchange with the R18 assay, but the trend is similar. It should
be recalled that the lipid concentration of the liposomes was
about 10-fold larger than that of the virions. The RET assay is
less suitable for monitoring the percent of virus fusion in the
second round due to a reduction in (unlabeled) virus concen-
trations. The calculated percents of second round fusion with
the RET assay are probably underestimated.
Next we studied the effect of temperature on the percents of
virions capable of fusing in the first and second rounds. To
account for the slower kinetics of fusion at lower temperatures,
we extended the incubation times at the lower temperatures.
The fractions of virions which fused with PC/PE liposomes at
lower temperatures were less than those at 37 °C, whereas for
PC/PE/PS/cholesterol liposomes an apparent maximum was
observed at 20 °C, but statistically it was not significant. In all
cases, a fraction of the released virions fused in the second
round.
It was of interest to examine whether partial fusion activity
of influenza virus also occurs toward liposomes which include
receptors for the virus, e.g. gangliosides (28). In Fig. 1, we
illustrate the kinetics of fusion of influenza virus with PC/PE
liposomes containing 5 mol% of the ganglioside GD1a. At 37 °C,
the initial rate of fusion is faster than at 20 °C, but after 2 min
the extent of fusion at 20 °C exceeds that at 37 °C. This pattern
is similar to earlier observations (20) and is explained by the
fact that both fusion and inactivation rate constants increase
with temperature (3, 13, 14). The final extents of fusion (Table
III) demonstrate partial fusion activity of the virus toward
TABLE III
Final intensity (I) levels and percents of virions fusing for influenza virus labeled by R18 interacting with excess of liposomes:
effect of the ganglioside GD1a
In liposomes containing GD1a, its content was 5 mol%. The molar ratio of PC to PE was 2:1. See Table I for details. The virus was from a different
batch than in Table I. The first two and the last three experiments were on different days.
Liposome
composition Temperature
First round Time of incubation
at pH 5
Second round
I (%) % fusion activity I (%) % fusion activity
(°C)
PC/PE 37 8.8 6 2 15 min
34.6 6 3 38.5 6 3 6 h
PC/PE/GD1a 37 26.9 6 4.5 15 min
54 6 5 60 6 5 6 h
—a 59.1 6 2 65.7 6 3 6 h
37 34.5 6 4 15 min 26.2 6 2 28.5 6 2
55 6 4 61 6 4 6 h 31.2 6 2 34 6 2
20 50.4 6 1 55 6 1 1 h 22 6 3 24 6 3
62 6 1 69 6 1 8 h 28.1 6 3 31 6 3
—a 66 6 3.5 73.1 6 4 8 h
4 47.9 6 1 53.5 6 1 7 h
54.5 6 2 60.5 6 2 24 h
(RET) 37b 24 6 2 60.2 6 5 6 h
20b 28.2 6 2.8 70.8 6 7 8 h
a,b These cases employed another batch of virus for a comparison between the results with the R18 assay (a) and the RET assay (b). See Table
II for details.
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PC/PE/GD1a liposomes and the ability of the unfused virus to
fuse when released after a long incubation time with the lipo-
somes at pH 5.
The effect of temperature on the final extents of fusion of
Sendai virus and influenza virus with erythrocyte ghosts is
shown in Tables IV and V, respectively. In both cases, a de-
crease in temperature results in a significant decrease in final
extents of fusion.
In both cases, the release of bound virus (after 20 h of
incubation) resulted in its partial fusion activity toward eryth-
rocyte ghosts, albeit reduced relative to the first round. It
should be noted that the final extents of fusion in the second
round (Tables IV and V) are underestimates, since the concen-
trations of particles were smaller, while keeping the ratios the
same as in the first round. Control experiments (see Table V)
demonstrate that lower particle concentrations result in
smaller extents of fluorescence increase.
We performed another test for the hypothesis that a fraction
of the virions bind in nonfusing conformations to the target
membranes. In this test we used PC/PE/GD1a liposomes. Fol-
lowing a 6-h incubation at pH 5 and 37 °C, where the extent of
fluorescence reached equilibration, new R18-labeled virions
were added to the medium (same amount as in the beginning of
the experiment). We observed dequenching due to the freshly
added virus (29.8% 6 5.8% after another 6 h). Addition of
labeled virions to erythrocyte ghosts after 20 h also resulted in
dequenching, 22% 6 3.8 with influenza virus and 17.7% 6 4.9
with Sendai virus. This result also rules out the possibility that
the target membranes were inactivated by the incorporation of
fusion-inhibiting molecules.
DISCUSSION
The phenomenon of partial fusion activity of viruses toward
certain target membranes is distinct from the phenomenon of
low pH inactivation. We have pointed out that Sendai virus (3,
5–7) and HIV-1 (8) exhibit at neutral pH partial fusion activity
toward liposomes, but no inactivation has been observed. In the
case of influenza virus, low pH inactivation did reduce the final
extents of fusion with liposomes of a variety of compositions,
but 100% of the inactivated virions fused with PS liposomes
albeit at a very slow rate (4). It is remarkable that the virus
released from the liposomes after long incubation at pH 5 could
still fuse in the second round, but the fractions of virions that
could fuse in the second round were 2/3 to 1/3 of those fusing in
the first round. In the case of Sendai virus (3), the correspond-
ing reduction was 5/6 to 2/3. Thus, most of the reduction in the
percent of fusion-active influenza virions is due to low pH
inactivation, and part might be due to the loss of activity
resulting during the sequence of binding and release that
might have impaired the structure and function of viral
glycoproteins.
In experiments with erythrocyte ghosts, the fractions of Sen-
dai and influenza virions that could fuse in the second round
were about 1/2 and 1/6 to 1/4, respectively. Again, the reduced
fraction in the case of influenza virus might be largely due to
low pH inactivation and partly due to dilution of particle con-
centrations in the second round.
Our experiments eliminate the possible explanation for par-
tial fusion activity that the virus preparation is heterogeneous,
in the sense that a certain fraction of the virions cannot induce
membrane destabilization of membranes of certain composi-
tions, although binding can occur. The experiments demon-
strate that the virions that did not fuse in the first round are
not necessarily incapable of fusing, since upon their release a
certain fraction can fuse. Thus we tend to accept the proposal
that partial fusion activity is a manifestation of heterogeneity
at the viral surface. It has been formulated (3) that if virus
binding to a liposome does not occur at an “active” (viral) site,
fusion will not occur. If this binding is essentially irreversible
under the given conditions, as was indeed found for Sendai
virus (6), then all of the virions may be bound in the presence
of large excess of liposomes (Tables I and III), but a certain
fraction will remain unfused. If such an attached virus is re-
leased from the liposome, it has the same chance as any other
virus in the population to fuse with liposomes by forming an
attachment via an active site.
The results of fusion with PC/PE liposomes without ganglio-
sides demonstrate a reduction in the final extents at lower
temperatures than 37 °C and, consequently, a reduction in the
percent of fusing virions. This result is particularly interesting
in view of the fact that the rate of low pH inactivation is
dramatically reduced upon lowering the temperature (3, 13, 14,
20). Truly, a situation can arise where the enhanced rate of low
pH inactivation at higher temperatures can result in a reduc-
tion in the final extents of fusion. Such differences can also
reflect differences in viral strains. We propose two explanations
which are not mutually exclusive. The enhanced percentage of
virions that can fuse with PC/PE liposomes and erythrocyte
ghosts at 37 °C than at 20 °C or 4 °C, might be due to the larger
tendency of bound colloidal particles to dissociate upon eleva-
tion of the temperature (29). Thus, the dissociated virions have
a second chance to bind via sites which promote fusion. It was
FIG. 1. Fusion of R18-labeled influenza virus with ganglioside-
containing liposomes. R18-labeled influenza virus (10 mg/ml viral
protein) was added to PC/PE (2:1) liposomes containing 5 mol% GD1a (25
mM total lipid concentration) in a final volume of 1.5 ml. Following a
15-min incubation period at pH 7.4, the medium was acidified to pH 5.0
and fusion was monitored as a function of R18 fluorescence dequench-
ing, as described under “Methods.” Experiments were carried out both
at 37 °C (a) and 20 °C (b).
TABLE IV
Final extents of fusion of Sendai virus with erythrocyte ghosts:
effect of temperature on percent of virus fusion
Temperature First round Second round
37 °C 65.1 6 3.9 31.1 6 4.6
15 °C 42.8 6 4.2 19.3 6 6
TABLE V
Final extents of fusion of influenza virus with erythrocyte ghosts:
effect of temperature on percent of virus fusion
Temperature First round Second round
37 °C 63.4 6 3.6 17.1 6 5
20 °C 36.6 6 1 6.1 6 3
15 °C 20.1 6 2.5 NDa
37 °C (batch 2) 58.8 6 4
37 °C (batch 2) 39.2 6 3.2
(2-fold dilution of virions and cells)
a ND, not determined.
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found (30) that the final extents of fusion of Sendai virus with
didodecyl phosphate vesicles increase with temperature. The
detailed analysis of fusion kinetics indicated indeed a signifi-
cant increase in the rate constant of dissociation with temper-
ature. In addition, at higher temperatures the viral glycopro-
teins might arrange themselves in a configuration which is
more optimal for fusion.
The concept that site heterogeneity in the viral surface may
manifest itself in partial fusion activity may be generalized in
the sense that viral glycoproteins or peptides may form several
intermediate states in the target membrane (31, 32). Again, if
certain intermediate states which do not lead to completion of
the fusion process are formed irreversibly, then a fraction of the
virions would remain unfused. Evidence for essentially irre-
versible association of peptides in the target membrane has
recently been presented in the case of HIVarg (33).
We have pointed out that in many cases influenza and Sen-
dai virions have partial fusion activity toward liposomes but
not cells. It is possible that, when the virus binds to the cellular
surface via an inactive site on the virus, or alternatively an
inactive intermediate state is created in the vicinity of the
attachment site, there is geometrically a chance of forming a
contact with the cellular surface via another active site.
In the experiments conducted in this study, the mechanism
of partial fusion activity of these viruses toward erythrocyte
ghosts is not necessarily the same as in the case of liposomes,
since the percent of fusing virions would be increased by in-
creasing ghost concentrations, whereas with the liposomes (Ta-
bles I and III) any further increase in liposome concentrations
would increase the final extents of fusion only slightly. Hence,
the major effect could be due to saturation of the ghosts’ mem-
branes with respect to viral glycoproteins (3). According to this
reasoning, the dramatic decrease in the final extents of fusion
at lower temperatures might be the effect of temperature on
the capacity of the ghosts’ membranes to incorporate the viral
glycoproteins. However, there are cases of partial fusion activ-
ity of Sendai virus and influenza virus toward erythrocyte
ghosts in large excess (7, 15) and, more dramatically, a very
small fraction of bound HIV-1 particles fuse with erythrocyte
ghosts (8) or CD41 target cells (16). Our results demonstrate
that influenza or Sendai virions released from erythrocyte
ghosts after 20 h of incubation can still fuse with the target
cells under the same conditions, similarly to the liposome ex-
periments. This result might imply that unfused virions bound
to a cellular membrane may have a certain probability of fusion
with similar target membranes following their release.
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